Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis
1. 系统已在2026-05-21 15:36:26对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s00415-026-13778-1
文献链接: https://link.springer.com/10.1007/s00415-026-13778-1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Eugenia Filippakopoulou; Maria Gavriilaki; Marianthi Arnaoutoglou; Vasilios Kimiskidis; Simone Di Giovanni
全文下载地址: https://link.springer.com/content/pdf/10.1007/s00415-026-13778-1.pdf

